Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for pharma and healthcare. Its principal products include containment solutions, drug delivery systems, medical devices, diagnostic, analytical services, visual inspection machines, assembling and packaging machines, and glass forming machines. The company was founded in 1949 and is headquartered in Piombino Dese, Italy. Stevanato Group S.p.A. operates as a subsidiary of Stevanato Holding S.R.L.
P/E ratio for Stevanato Group S.p.A. (STVN)
P/E ratio as of 2023: 44.92
According to Stevanato Group S.p.A.'s latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 44.92. At the end of 2022 the company had a P/E ratio of 31.10.
P/E ratio history for Stevanato Group S.p.A. from 2018 to 2023
PE ratio at the end of each year
| Year | P/E ratio |
|---|---|
| 2023 | 44.92 |
| 2022 | 31.10 |
| 2021 | 38.91 |
| 2020 | 54.26 |
| 2019 | 118.43 |
| 2018 | 0.00 |